GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novo Nordisk AS (LTS:0TDD) » Definitions » Other Current Payables

Novo Nordisk AS (LTS:0TDD) Other Current Payables : $0 Mil (As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Novo Nordisk AS Other Current Payables?

Novo Nordisk AS's Other Current Payables for the quarter that ended in Sep. 2024 was $0 Mil.

Novo Nordisk AS's quarterly Other Current Payables increased from Mar. 2024 ($0 Mil) to Jun. 2024 ($0 Mil) but then stayed the same from Jun. 2024 ($0 Mil) to Sep. 2024 ($0 Mil).

Novo Nordisk AS's annual Other Current Payables declined from Dec. 2021 ($0 Mil) to Dec. 2022 ($-0 Mil) but then increased from Dec. 2022 ($-0 Mil) to Dec. 2023 ($0 Mil).

Novo Nordisk AS Other Current Payables Historical Data

The historical data trend for Novo Nordisk AS's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novo Nordisk AS Other Current Payables Chart

Novo Nordisk AS Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Novo Nordisk AS Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Novo Nordisk AS Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Novo Nordisk AS Other Current Payables Related Terms

Thank you for viewing the detailed overview of Novo Nordisk AS's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.

Novo Nordisk AS Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novo Nordisk AS (LTS:0TDD) » Definitions » Other Current Payables
Comparable Companies
XSWX:SGKN XSWX:SREN XSWX:WKBN XSWX:MOZN XSWX:GMI XSWX:LLBN XSWX:BEKN XSWX:ASWN XSWX:BELL XSWX:EFGN LLY JNJ ABBV MRK XSWX:ROG XSWX:NOVN LSE:AZN AMGN PFE XPAR:SAN
Traded in Other Exchanges
NONOF:USA NVO:USA NOVOB:Mexico NVO:Mexico NOVOBc:UK 0QIU:UK NOVO B:Denmark NOV:Germany NOV:Germany NOVA:Germany NOV:Germany NOV:Germany NOVA:Germany N1VO34:Brazil NOV:Bulgaria NNO2:Austria
Address
Novo Alle 1, Bagsvaerd, DNK, 2880
Website
https://www.novonordisk.com
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Novo Nordisk AS Headlines

No Headlines